Navigation Links
Medizone International, Inc. Approves Repurchase of Global Marketing Rights

SAN FRANCISCO, Dec. 16 /PRNewswire-FirstCall/ -- Medizone International, Inc. (OTC Bulletin Board: MZEI) reported that its Board of Directors and the Board of Medizone New Zealand Ltd., a joint venture in which Medizone International Inc. holds a 50% interest, agreed on December 14, 2009 to unwind the joint venture and reconvey to Medizone International all global marketing rights of the company's intellectual property. Medizone International's Chairman, Edwin G. Marshall said, "Time has eroded the relevance of the joint venture we established in 1995 and the partnership no longer fits with the business plan of Medizone International moving forward. We have mutually agreed that it is in the best interest of both Medizone New Zealand Ltd., and Medizone International, Inc., to find a fair basis to terminate the marketing rights and to wind up the joint venture." The transaction should be concluded by December 31, 2009.

The parties agreed that Medizone International Inc. would pay Solwin Investments Ltd., the New Zealand principal in Medizone New Zealand Ltd. $125,000 in shares of Medizone International common stock priced at $0.40 per share, $0.015 above the closing market price on the day agreement was reached. The joint venture held licensing and marketing rights for Medizone products in Australia and its territories, New Zealand and its territories, the South Pacific Islands, the Philippines, Indonesia, Viet Nam, Cambodia, Laos, Thailand, Malaysia and Singapore. Noted Marshall, "In recapturing all marketing and licensing rights to these territories, Medizone International now retains global marketing and licensing rights for all of its future products, paving the way for implementation of its revised business plan."

Medizone International, Inc., is a research and development company engaged in developing its AsepticSure(TM) technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. Full-scale mock-up trials are scheduled to begin in January at its research laboratories located in Innovation Park, Queens University in Kingston, Ontario, Canada.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

           Investor Relations: 415-868-0300 / web site:

SOURCE Medizone International, Inc.

SOURCE Medizone International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medizone International, Inc. Announces OTCBB Listing
2. Medizone Expects OTCBB Listing
3. Medizone International, Inc. Has Filed for Patent Protection for Its AsepticSure(TM) Hospital Sterilization System
4. Medizone International, Inc. (MZEI.PK) Announces it has Established its Own BSL2A Certified Laboratory Located in Innovation Park, Queens University at Kingston, Ontario, Canada.
5. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
6. Medizone Announces a Second Round of Trials Have Begun.
7. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
8. Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc.
9. AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation
10. Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
11. CEO and Founder of Project Lifesaver International, Gene Saunders, Selected to Receive Two Awards From Local Community
Post Your Comments:
(Date:12/1/2015)... Angeles, CA (PRWEB) , ... December 01, 2015 , ... ... coalition of obesity groups has filed a discrimination claim against the U.S. Department of ... coverage in their Affordable Care Act (ACA) plans are breaking the clause in the ...
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... Houston, TX (PRWEB) , ... December 01, 2015 , ... ... owner of Vitenas Cosmetic Surgery, has been named by MedEsthetics magazine as the Best ... best of the best among the many elite aesthetic physicians honored by the industry ...
(Date:12/1/2015)... ... 2015 , ... Growth in medical payments per workers’ compensation claim in Louisiana ... and nonhospital care, according to a recent study by the Workers Compensation Research Institute ... found medical payments per claim with more than seven days of lost time continued ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Va. , Dec. 1, 2015  AccuTEC ... unveiled a new corporate logo and brand identity ... the design and engineering of bladed products where ... --> --> Serving manufacturers ... glass, and auto glass equipment, AccuTEC,s product lines ...
(Date:12/1/2015)... , Dec. 1, 2015 During the ... San Francisco, CA , Medinol ... the coronary marketplace. During a satellite symposium, "The ... Design to Minimize Restenosis", a renowned physician panel ... Medinol NIRxcell™ CoCr Coronary Stent System and the ...
(Date:12/1/2015)... ) has ... and Disposables Market by product, by Animal - ... offering. --> ) has announced ... Disposables Market by product, by Animal - Global ... --> Research and Markets ( ...
Breaking Medicine Technology: